E
EpiVax Therapeutics
0 followers
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host.
Org chart
Board & advisors
Dan Adams
Chairman, Board of Directors
Richard Lipkin
Director
Manon Cox
Advisor
Judy Lieberman
Advisor
Dominique Bridon
Advisor
Amy Rosenberg
Advisor
Eleanor Ramos
Advisor